Kedudukan dalam Saham
#42192
GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced... GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company's portfolio includes treatments for a variety of these conditions, such as COVID-19, and illnesses like paratuberculosis (Johne's disease), currently in its Stage III clinical phase, as well as mad cow and chronic wasting diseases, and common bacterial infections like E.coli and salmonella. Furthermore, GeneThera is developing a vaccine specifically targeting Mycobacterium avium subspecies paratuberculosis bacteria. Utilizing its innovative Molecular Robotic/AI Platform and a strategic therapeutic framework, the company strives to inhibit the spread of animal-borne diseases and improve control over zoonotic infectious agents. GeneThera, Inc. operates out of Westminster, Colorado.
Harga Saham
$0.0001
Disegerakkan terakhir: 2025-03-10
Perubahan (1 tahun)
0.00%
Perdagangan GeneThera, Inc. (GTHR)
Harga GTHR dengan permodalan pasaran b
Modal pasaran bagi GeneThera, Inc.(GTHR)
Modal Pasaran: $3.53K
Sehingga August 2026, GeneThera, Inc. mempunyai modal pasaran sebanyak $3.53K. Ini menjadikan GeneThera, Inc. syarikat ke-42192nd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran GeneThera, Inc. dari 2012 hingga 2026
GTHR berbanding dengan 5 teratas yang paling popular stocks
| Harga GTHR |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.383T
|
+152,373,604,768.38%
|
|
|
|
|
$4.423T
|
+125,202,128,508.49%
|
|
|
|
|
$4.160T
|
+117,757,412,837.50%
|
|
|
|
|
$3.663T
|
+103,688,673,463.54%
|
|
|
|
|
$2.891T
|
+81,834,950,236.82%
|
